SF3B1 is the most frequently mutated splicing factor in cancer. While some heterozygous hotspot mutations in SF3B1 confer growth advantages to cancer cells, these mutations also provide opportunities for finding cancer vulnerabilities. Differently from other animal models, we found that SF3B1 cancer mutations can be maintained in homozygosis when mimicked in its C. elegans ortholog sftb-1. These mutations caused alternative splicing (AS) defects in C. elegans, as it occurs in SF3B1-mutated human cells. By using sftb-1 mutants in an RNAi screen we identified U2 snRNP components as potential targets for synthetic lethality. Finally, we detected genetic interactions between sftb-1 mutants and cancer-related mutations in uaf-2/U2AF1 or rsp-4/SRSF2, demonstrating that our model can identify mutations that are mutually exclusive in human tumors. Thus, we have established a multicellular model amenable for high-throughput screening to uncover synthetic lethal interactions that could selectively kill cancer cells harboring SF3B1 mutations. 
INTRODUCTION
Deregulated RNA splicing is emerging as a new hallmark of cancer following the discovery of several splicing factor genes harboring somatic mutations in different tumor types (Urbanski et al., 2018) . SF3B1, a core component of the U2 snRNP, is the most frequently mutated splicing factor in human cancers.
Somatic heterozygous mutations in SF3B1 are particularly prevalent in myelodysplastic syndromes (MDS)-up to 80% in refractory anemia with ring sideroblasts (Papaemmanuil et al., 2011; Yoshida et al., 2011; Malcovati et al., 2015) ; and in 15% of chronic lymphocytic leukemia (CLL) (Quesada et al., 2011; Wang et al., 2011; te Raa et al., 2015) . SF3B1 mutations have also been reported in solid tumors, including 20% of uveal melanomas (UM) (Furney et al., 2013; Harbour et al., 2013; Martin et al., 2013) , 3% of pancreatic ductal adenocarcinomas (Biankin et al., 2012) , and 1.8% of breast cancers (Maguire et al., 2015) . RNA-sequencing (RNA-seq) analyses in different tumor types and cell lines with SF3B1 missense mutations, including the most prevalent substitution K700E, identified distinct alternative splicing (AS) defects (Darman et al., 2015; DeBoever et al., 2015; Liberante et al., 2019) .
Recently, CRISPR/Cas9 genome editing has allowed researchers to faithfully reproduce human pathological mutations in animal models. Human SF3B1 mutations have been introduced in cell lines (Alsafadi et al., 2016; Shiozawa et al., 2018; Gupta et al., 2019; Liberante et al., 2019) , but mimicking these mutations in multicellular organisms has only been achieved by conditional alleles in murine models (Xu et al., 2019) . Taking advantage of the extraordinary conservation of splicing factors across evolution and the ease of 5 genetic manipulation of C. elegans, we established a multicellular model to study SF3B1 cancer-related mutations. Since the spliceosome components, and particularly SF3B1, are being intensively studied as a target of antitumor drugs (Bonnal, Vigevani and Valcárcel, 2012; Effenberger, Urabe and Jurica, 2017; DeNicola and Tang, 2019) , the multicellular model of SF3B1 mutations described in this study would provide a convenient pre-clinical platform for identifying new targets and small molecules for use in cancer therapies.
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RESULTS
sftb-1, the C. elegans ortholog of SF3B1, is an ubiquitously expressed gene essential for development
The C. elegans protein SFTB-1 is 66% identical to human SF3B1 in terms of amino acid composition. Homology is particularly high at the HEAT domain, reaching 89% identity, and the most frequently mutated amino acids in cancer are conserved. The SFTB-1 sequence also conserves some of the U2AF ligand motifs (ULMs) that bind U2AF homology motifs (UHMs) present in other splicing factors ( Figure 1A and S1) (Loerch et al., 2018) .
As expected for a core splicing factor, the CRISPR-engineered endogenous fluorescent reporter mCherry::SFTB-1 showed ubiquitous expression in somatic and germ cells, being absent in mature sperm only (Figure 1b and 1c) . We also used CRISPR to generate the sftb-1(cer6) mutation, a deletion allele that produces a premature stop codon ( Figure S2a ) and causes an arrest at early larval stages, confirming that sftb-1 is essential for development (Figures 1d   and 1e ). sftb-1(cer6) homozygous animals completed embryonic development but arrested as larvae that could undergo few germ cell divisions (Figure S2b) , suggesting that maternal wild-type (WT) product can still be present in the early larva.
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Different sftb-1 missense mutations display additive effects when combined We edited the C. elegans genome to mimic the K700E mutation, the most frequent SF3B1 substitution in tumors. sftb-1[K718E] homozygous animals did not display any obvious phenotypes. Thus, we decided to reproduce two other SF3B1 cancer-related mutations. R625C is a particularly prevalent mutation in uveal melanoma, and Q534P is less common but is predicted to have a strong impact on SF3B1 structure due to its location in an -helix (Cretu et al., 2016 We were interested in producing animals with defective sftb-1 function resulting in a viable and traceable phenotype for investigating modifiers of altered SFTB-1 activity. Since the effects of MDS-related missense mutations were reported to be additive in the yeast SF3B1 ortholog Hsh155 (Carrocci et al., 2017) , we generated three strains with each of the possible pairs of mutations: K718E], sftb-1[Q552P, K718E], and sftb-1[Q552P, R643C] . None of the three double mutants showed an obvious phenotype. However, animals simultaneously carrying the three missense mutations sftb-1[Q552P, R643C, K718E] displayed several temperature-sensitive developmental defects including partial sterility, protruding vulva, and developmental delay (Figure 1f-1h and S3c-e). These results suggest that each of the three missense mutations provokes a functional impact that becomes unmasked only when the three mutations are combined.
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Distinct sftb-1 alleles produce alterations in alternative splicing and gene expression The most commonly described AS defect caused by cancer-associated SF3B1 mutations is the incorrect recognition of 3' splice sites, producing aberrant transcripts (Darman et al., 2015; DeBoever et al., 2015; Wang et al., 2016; Pellagatti et al., 2018; Shiozawa et al., 2018) (Figure 2a) . We investigated in C.
elegans the transcriptional consequences of the K718E mutation, an equivalent of the most frequent SF3B1 mutation K700E, by RNA-seq of two different strains with two independent K718E alleles (cer3 and cer7) and their WT siblings at the L4 stage. Then, we used rMATS for robust detection of differential AS events between mutant and WT worms (Shen et al., 2014) .
Using both splice junction and exon body reads, our analysis detected 21985 AS events, of which 134 were significantly altered (FDR < 0.05) ( Table S1) . A more restricted cut-off (inclusion level difference > 0.1), as used in a previous rMATS analysis of SF3B1-mutated samples (Pellagatti et al., 2018) , reduced the list of significant AS events to 78, with skipped exon (SE) being the most frequent event (Figures 2b and 2c) .
Then, we investigated whether the two sftb-1 alleles associated with a visible phenotype (the triple mutation allele cer39, and the deletion allele cer6) primarily induced cryptic 3' splice site selection. It is worth noting that, in this experiment, larvae were harvested and processed for RNA isolation at the L2 stage to avoid possible indirect effects due to developmental defects observed after this stage. Both alleles were associated with a high number of deregulated AS events as determined by rMATS (Figure 2b) , and the predominant alteration was also exon skipping (Figure 2c) . We then explored if there were 9 differentially expressed protein-coding (Figure 2d ) and non-coding (Figure 2e) transcripts in the three RNA-seq datasets (Table S2) . As expected, the highest number of significantly altered transcripts was observed in the cer6 allele.
In summary, we identified gene expression and alternative splicing alterations that are more frequent as sftb-1 function becomes progressively compromised, with SE being the predominant AS defect.
A subset of U2 snRNP and U2-associated components synthetically interacts with sftb-1 mutants
In the search for selective vulnerabilities in sftb-1 defective backgrounds, we hypothesized that sftb-1 mutant animals would be more sensitive to knockdown of other splicing factors than their WT counterparts. Based on a previous C. elegans RNA interference (RNAi) collection of splicing factors (Kerins et al., 2010) , we compiled and assayed a total of 104 RNAi clones targeting proteins that act in different steps of the splicing reaction. This led us to identify 27 splicing factors whose knockdown phenotype was enhanced in at least one of the three sftb-1 single mutants, suggesting possible synthetic interactions (Table S3) .
Among the 27 candidates, we selected 3 U2 snRNP components, including sftb-1, and 2 U2-associated proteins for further validation ( Figure 3A) . The identification of sftb-1 as a candidate certified our approach since it demonstrated that any RNAi affecting sftb-1-related functions would have a stronger effect on sftb-1 mutants. Since a partial loss-of-function mutant for the candidate teg-4 was available, we proceeded to validate the interaction between sftb-1 mutations and teg-4, the C. elegans ortholog of SF3B3, which physically interacts with SF3B1 HEAT repeats (Cretu et al., 2016) . We found that the K718E mutation exacerbated the phenotype of teg-4(oz210) at 20 o C (Mantina et al., 2009) , whereas the Q552P mutation did so to a lesser extent ( Figure 3B ).
Then, we validated the rest of the candidates using RNAi. As we had observed that sftb-1 mutations had an additive effect (Figure 1f-1h) , we reasoned that sftb-1 double mutants might be more sensitive to splicing perturbations than single mutants. Consistently, sftb-1(RNAi) led to an additive loss of function in double mutants, which arrested at earlier stages compared to WT worms Among the remaining U2 and U2-associated candidates, we selected mog-2/SNRPA1 and smr-1/SMNDC1 for further validation in the doublemutation backgrounds. Strikingly, whereas RNAi of mog-2 resulted in very low penetrant sterility in WT worms, the incidence of the phenotype incremented to over 70% in the three sftb-1 double-mutation strains (Figure 3e) . A similar synthetic phenotype was observed upon knockdown of smr-1 (Figure 3f ).
Finally, we further validated the synthetic interaction between teg-4 and sftb-1, as sftb-1 double mutants were more sensitive to teg-4(RNAi) (Figure 3g) .
Together, our results suggest that targeting other splicing factors such as SF3B3 to compromise their function can be an opportunity to selectively impair cancer cells harboring SF3B1 mutations.
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The C. elegans mutations equivalent to human U2AF1 S34P and SRSF2 P95H genetically interact with sftb-1[Q552P, R643C, K718E] mutants Along with SF3B1 mutations, recurrent missense mutations in U2 small nuclear RNA auxiliary factor 1 (U2AF1) and serine/arginine-rich splicing factor 2 (SRSF2) were discovered in hematological malignancies (Yoshida et al., 2011) , and later reported to be present in some solid tumors (Imielinski et al., 2012; Seiler, Peng, et al., 2018) . Somatic hotspot mutations in these three splicing factors are only found in heterozygosis and are mutually exclusive, suggesting redundant functional impact or limited tolerance to splicing perturbations.
Missense mutations in U2AF1 are commonly found at position S34, which corresponds to a residue located within the two zinc finger domains through which U2AF1 is thought to interact with the pre-mRNA (Ilagan et al., 2015) .
Similarly, SRSF2 is typically mutated at position P95, mainly bearing missense mutations but also in-frame insertions or deletions (Yoshida et al., 2011) .
Based on a recently reported synthetic interaction between Srsf2 P95H/+ and Sf3b1 K700E/+ in mice (Lee et al., 2018) , and on the fact that sftb-1 mutants were more sensitive to inactivation of some splicing factors (Figure 3) As expected for a core splicing factor, and as previously reported in zebrafish (An and Henion, 2012) and mice (Isono et al., 2005) , the C. elegans SF3B1 ortholog is essential for development. Cancer cells bear SF3B1 hotspot mutations in heterozygosis and depend on SF3B1 WT function for viability.
However, homozygous sftb-1 missense mutations are viable in C. elegans, although they generate defects that are unmasked when additional alterations in the spliceosome are introduced. Such a feature is advantageous for investigating vulnerabilities of SF3B1-mutated tumors, which are not only conferred by missense mutations, but also by the loss of one SF3B1 WT copy (Alsafadi et al., 2016; Paolella et al., 2017) .
Differently from MDS with SF3B1 mutations, where aberrant transcripts have been directly related to phenotypic traits (Dolatshad et al., 2015; Pellagatti et al., 2018) , transcripts affected by sftb-1[K718E] do not produce any obvious phenotypes. Still, Sf3b1 K700E/+ mice models only partially recapitulate the hematopoietic phenotype characteristic of MDS (Obeng et al., 2016; Mupo et al., 2017) and CLL (Yin et al., 2019) . In these models, the splicing alterations caused by Sf3b1 K700E/+ were similar to that reported in human tumors, but most of the affected transcripts were different, probably due to low conservation in intronic sequences.
RNA-seq of sftb-1[K718E] animals did not identify the aberrant use of alternative 3' splice sites (A3'SS) as the predominant splicing defect caused by this mutation, as has been observed in human cells (Darman et al., 2015; DeBoever et al., 2015; Alsafadi et al., 2016; Pellagatti et al., 2018; Shiozawa et al., 2018) . Indeed, in three distinct sftb-1 mutants, we found a mild effect on AS, with SE being the most abundant splicing defect. Such disparity in the consequences of the mutation K700E/K718E between humans and nematodes may be explained by different factors. First, diverse computational pipelines have been used to assess differences in alternative splicing between WT and SF3B1-mutated samples, resulting in distinct conclusions. For instance, Liberante et al. reanalyzed previously published data and found that SF3B1 mutation was mostly associated with differential skipped exon events, rather than A3'SS selection (Liberante et al., 2019) . Second, intronic elements directing splicing have evolved differently in C. elegans compared to other organisms. C. elegans introns are typically shorter, do not have a consensus 15 branch site (BS) sequence, and the vertebrate polypyrimidine (Py) tract is replaced by the consensus UUUUCAG/R sequence (Morton and Blumenthal, 2011) . Third, only ~35% of genes are alternatively spliced in C. elegans (Tourasse, Millet and Dupuy, 2017) compared to 95% in humans (Pan et al., 2008) . Fourth, cell type-specific alternative isoforms generated by sftb-1 mutations could have been underrepresented in our analyses as we sequenced the transcriptome of whole animals, and A3'SS selection can be regulated in a tissue-specific manner in C. elegans (Ragle et al., 2015) . And fifth, the nonsense-mediated decay (NMD) system could efficiently eliminate transcripts with A3'SS resulting from sftb-1 mutations, as occurs in human cells (Darman et al., 2015) . However, we did not detect predominance of downregulation among the differentially expressed transcripts (Figures 2D and 2E ).
Beyond its action on A3'SS usage, SF3B1 missense mutations could have an impact on the structure, the interaction with other proteins in the spliceosome, or the robustness of the protein. In fact, the small molecule H3B-8800, which induces lethality in spliceosome-mutant cancers by modulating the SF3b complex, affects AS activity similarly in WT and in SF3B1 K700E human cells (Seiler, Yoshimi, et al., 2018) . Therefore, SF3B1-mutated cells present vulnerabilities that can be exploited in synthetic lethal screens. We found that sftb-1 mutants are sensitive to RNAi of different splicing factors, including itself, and we further validated the synthetic interaction with the inactivation of other components of the U2 snRNP. These results point to other components of the spliceosome as targets to preferentially kill cells with deficiencies in SF3B1 activity. Knowing the suitability of sftb-1 mutants for RNAi screens, the collection of RNAi clones to be tested should be expanded, with particular interest placed on deubiquitinases and chromatin factors that have been related with SF3B1 functions (Kfir et al., 2015; Paolella et al., 2017) .
Pladienolide and derivatives have been proven to be effective in selectively killing cells with SF3B1 mutations (Obeng et al., 2016; Seiler, Yoshimi, et al., 2018; Wu et al., 2018) . We tested Pladienolide B and Sudemycin D6 in WT and sftb-1 mutant worms and we did not observe any effects ( Table S4 ). The inhibitory activity of these drugs is likely dependent on protein structure, which may differ from nematodes to humans. In fact, human VAL1078 corresponds to ILE1096 in C. elegans, and a mutation to isoleucine or alanine at this position is sufficient to render SF3B1-mutant cells insensitive to Pladienolide B (Teng et al., 2017) . Since editing of this residue in the SF3B1 yeast ortholog Hsh155 sensitizes S. cerevisiae to splicing inhibitors (Hansen et al., 2019) , these drugs could also inhibit SF3B1 chimeric proteins in C. elegans. SF3B1 mutations are mutually exclusive with other splicing factor mutations present in tumors. U2AF1 and SRSF2 missense mutations are reported in 11% and 12-15% of MDS, respectively (Xu et al., 2019) , and very rarely overlap with SF3B1 mutations, which are present in 17-28% of MDS patients (Lee et al., 2018; Seiler, Peng, et al., 2018) . Hence cells may not handle all the AS defects produced by the combination of mutations in any of these three proteins. To further validate our model as a tool for identifying vulnerabilities in cells with compromised SF3B1 function, we mimicked U2AF1 S34F and SRSF2 P95H mutations in C. elegans and detected a functional interaction between both mutants and our sftb-1 mutant carrying the three missense mutations. 
Methods
Caenorhabditis elegans
C. elegans strains were maintained using standard methods (Stiernagle, 2006; Porta-de-la-Riva et al., 2012) at the specified temperature. Before conducting the experiments, strains were grown for at least two generations at the experimental temperature. Unless otherwise specified, we used Bristol N2 as the WT strain. Mutant strains with single sftb-1 missense mutations (CER218, CER220, CER236, and CER238) were outcrossed x2. WT siblings resulting from the second outcross were given specific strain names (CER217, CER221, CER237, and CER239, respectively) and kept for closer comparison. CER351, CER442 and CER450 strains were outcrossed x2. In order to maintain the cer6 deletion, heterozygous mutants were crossed with the EG7893: oxTi615 unc-119(ed3) III strain so that a red fluorescent marker was inserted 0.15 cM away from the sftb-1 WT locus.
Protein alignments
H. sapiens SF3B1 (Uniprot: O75533) and C. elegans SFTB-1 (Uniprot: G5EEQ8) protein sequences were aligned using the T-Coffee algorithm (Notredame, Higgins and Heringa, 2000) with default settings. Figure S1 was generated with Jalview (Waterhouse et al., 2009) .
CRISPR/Cas9 mutant and reporter strains
Specific guide RNAs were designed using both Benchling (www.benchling.com) and CCTop (Stemmer et al., 2015) online tools. All CRISPR/Cas9 mutant and reporter strains were obtained following a co-CRISPR strategy (Kim et al., 24 2014) using dpy-10 as a marker to enrich for genome-editing events. In all cases, mixes were injected into gonads of young adult P0 hermaphrodites using the XenoWorks Microinjection System and following standard C. elegans microinjection techniques. F1 progeny was screened by PCR using specific primers and F2 homozygotes were confirmed by Sanger sequencing. As we optimized the protocol for CRISPR/Cas9 genome editing in our laboratory while preparing this manuscript, different reagents and conditions were used to produce the distinct mutants. The sftb-1(cer6) deletion mutant allele was obtained by nonspecific double-strand break repair on our first attempt to generate the K718E mutation. Only in this experiment, guide RNAs and Cas9 were expressed from plasmids that were purified with the NucleoBond® Xtra Midi Kit (Macherey-Nagel). In the remaining mixes, ribonucleoprotein complexes containing crRNA, tracrRNA and Cas9 were annealed at 37 o C for 15 minutes prior to injection. All the reagents and injection mixes used in this study are listed in Table S5 .
C. elegans microscopy
Worms were mounted on 2% agar pads with 10 mM tetramisole hydrochloride and imaged using a ZEISS Axio Observer Z1 inverted fluorescence microscope.
Images were processed using ZEISS ZEN 2012 (blue edition) software and Fiji.
Gonad dissection and DAPI staining
Worms expressing mCherry::SFTB-1 were anesthetized with 0.33 mM tetramisole hydrochloride and their heads cut using a pair of 25-gauge needles to extrude gonad arms. Released gonads were fixed in 4% paraformaldehyde in PBS for 20-30 minutes and washed with PBS + 0.1% Tween 20 for 10 minutes.
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After performing 3 washes, gonads were transferred to a microscope slide and mounted using 10 µl DAPI Fluoromount-G® (SouthernBiotech). Images were acquired the same day to avoid mCherry signal loss.
sftb-1 deletion mutant larval arrest
Synchronized L1-arrested F2 worms from heterozygous sftb-1(cer6)/oxTi615
P0s were seeded onto NGM plates with OP50 and imaged after 48 hours of growth at 20 o C using a ZEISS Axio Observer Z1 inverted fluorescence microscope at 10X magnification. Body length was measured manually by drawing the midline of the worm using the freehand line tool in Fiji. Progeny were counted 36-48 h after passages.
Phenotypic characterization
RNA isolation
In order to study the transcriptional consequences of the K718E mutation, we used two homozygous mutant lines (CER218 and CER220) derived from two independent CRISPR/Cas9 events (cer3 and cer7 alleles, respectively), and the corresponding WT siblings (CER217 and CER221). Synchronized L4 animals were collected in M9 after growing for 41 hours at 20 o C and total RNA was isolated using TRI Reagent (MRC, Inc.) and the PureLink® RNA Mini Kit (Ambion), following the manufacturer's instructions.
sftb-1(cer6) homozygous larvae were obtained by automatically sorting non-red animals from a synchronized CER191 population grown at 20 o C for 23 hours, using the COPAS Biosorter system (Union Biometrica). We conducted two biological replicates with an average of 1.6% non-red recombinants and 5.25% red contaminants in the samples. The same size and fluorescence window was used to sort two N2 WT populations collected under the same experimental conditions. Two CER276 biological replicates were collected independently without sorting, after growing for 23 hours at 20 o C. Total RNA from the six samples was extracted using TRI Reagent, followed by aqueous and organic phase separation using 1-Bromo-3-chloropropane (Sigma-Aldrich), and RNA was precipitated with 2-propanol. After treatment with TURBO DNase (Thermo Fisher Scientific), RNA was purified following a phenol/chloroform extraction protocol.
In all cases, total RNA was quantified by Qubit® RNA BR Assay kit (Thermo Fisher Scientific) and the integrity was checked by using the Agilent RNA 6000 Nano Kit (Agilent).
RNA sequencing
Four RNA-seq libraries (from CER217, CER218, CER220, and CER221 strains) were prepared with the KAPA Stranded mRNA-Seq Illumina® Platforms Kit (Roche-Kapa Biosystems) following the manufacturer's recommendations.
Briefly, 500 ng of total RNA was used as the input material, the poly-A fraction was enriched with oligo-dT magnetic beads and the mRNA was fragmented.
Strand specificity was achieved during the second strand synthesis performed in the presence of dUTP instead of dTTP. The blunt-ended double stranded cDNA was 3´adenylated and Illumina indexed adapters from TruSeq™ Stranded Total RNA Sample Preparation Kit with Ribo-Zero Gold (Illumina) were ligated.
The remaining six samples (two biological replicates from N2, CER276, and homozygous sftb-1(cer6) larvae) were prepared using the TruSeq™ Stranded Total RNA kit protocol (Illumina). Briefly, rRNA was depleted from 500 ng of total RNA using the Ribo-Zero Gold rRNA Removal Kit and fragmented by divalent cations, with a major peak at 160 nt. Following the fragmentation, first and second strand synthesis was performed, also ensuring the library directionality. The cDNA was adenylated and ligated to xGen® Dual Index UMI Adapters (IDT) for paired-end sequencing. 
Bioinformatic analysis
RNA-seq reads were mapped against C. elegans reference assembly (WBcel235.87) with STAR (Dobin et al., 2013) . Genes and transcripts were quantified with RSEM (Li and Dewey, 2011) . Differential expression analysis was performed with DESeq2 R package (Love, Huber and Anders, 2014) , and detection of differential alternative splicing events was done with rMATS (Shen et al., 2014) .
RNAi screen
Information about the selected splicing genes was collected from SpliceosomeDB (Cvitkovic and Jurica, 2013) or from the literature. RNAi clones were obtained from the ORFeome library (Rual et al., 2004) or the Ahringer library (Kamath et al., 2003) and clone insert size was validated by PCR. For screening, we used 24-well plates containing NGM supplemented with 50 µg/mL ampicillin, 12.5 µg/mL tetracycline and 3 mM IPTG. Each well was seeded with 80 µl of bacterial culture and dsRNA expression was induced overnight at room temperature. WT and mutant worms were tested in duplicates. Between 10 and 20 worms synchronized at the L1 stage were seeded in each well, and phenotypes were scored visually at the adult stage (72-96 h post-seeding at 25 o C). Bacteria expressing dsRNA against gfp were used as negative control.
Interaction between teg-4 and sftb-1 mutations
Worms of the indicated genotype were singled onto individual 35-mm NGM plates with OP50 at the L4 stage and transferred to new plates every 12 hours until all eggs were laid. Numbers of dead embryos and hatched larvae were scored 24 and 48 hours after passages, respectively. Since the double mutant sftb-1(K718E); teg-4(oz210) could not be maintained in homozygosis, F1 worms from sftb-1(K718E); teg-4(oz210/+) P0 worms, including animals homozygous and heterozygous for teg-4(oz210), were picked at the L4 stage and their progeny scored. These F1s were genotyped after conducting the experiment to include only sftb-1(K718E) and sftb-1(K718E); teg-4(oz210) data.
Validation of candidates from the RNAi screen
In all cases, we used 55-mm or 35-mm NGM plates supplemented with 50 µg/mL ampicillin, 12.5 µg/mL tetracycline and 3 mM IPTG, seeded with specific RNAi bacterial clones. RNAi targeting gfp was used as negative control.
In Figures 3c and 3d , synchronized L1-arrested worms of the indicated genotypes were seeded onto 55-mm plates, and imaged directly on the plates after 48 hours of growth at 25 o C using a stereomicroscope. Body length was determined automatically with WormSizer (Moore, Jordan and Baugh, 2013) .
In Figures 3e-g, synchronized L1 -arrested animals were seeded onto 55-mm plates and separated into individual 35-mm plates at the L4 stage. Worms were transferred every 24 hours and the presence of dead embryos was determined 24 hours after passages.
Number of germ cells assay
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WT or sftb-1(cer6) homozygous worms were collected at the indicated time points, fixed using Carnoy's solution (60% absolute ethanol, 30% chloroform, 10% acetic acid), and washed three times in PBS + 0.1% Tween 20. Whole worms were transferred to a microscope slide and stained with DAPI Fluoromount-G® in order to visualize and count germ cell nuclei.
Spliceosome inhibitors experiments
Experiments in liquid media were conducted in 96-well plates. 25 µl of dead OP50 resuspended in a mix of freshly prepared S Medium (Stiernagle, 2006) , 4 µg/ml cholesterol, 250 µg/ml streptomycin, and 62.5 µg/ml tetracycline were added to each well. Subsequently, 25 µl 2.4X drug and 10 µl L1-arrested worms at a density of 1-2 worms/µl were added to each well. Each condition was tested in duplicate in the same 96-well plate. Plates were sealed with parafilm and incubated in a humid chamber with gentle agitation at room temperature for the indicated time period. 25 µl water (experiments 1-3) or 0.5% DMSO (Sigma-Aldrich) (experiments 4 and 6) were used as negative controls. In experiment 5, 50 µM Sudemycin D6 or 0.5% DMSO were injected into the gonads or intestine of young adult hermaphrodites using standard microinjection techniques, and injected animals were recovered in individual 35-mm NGM plates with OP50 and incubated at 20 o C.
Statistical analyses
In all figure legends, 'N' denotes the number of independent replicate experiments performed, while 'n' indicates the total number of animals analyzed in each condition (different genotypes are separated by commas). Statistical 31 analyses were performed in GraphPad Prism 6 and R. Statistical tests used are reported in the figure legends. Figures 1a, 1d, 1f-h, 2b-e, 3b-g, 4 , S2b, and S3c-e were generated by using the ggplot2 R package.
Data availability
The RNA sequencing data generated in this study have been deposited in the Gene Expression Omnibus repository and are available under the accession number GEO: GSE129642. Table S1 . Alternative splicing analysis of sftb-1 mutants by rMATS. 
